University of Thessaly (UTH)
Ο ρόλος του επαγόμενου από την υποξία μεταγραφικού παράγοντα HIF-2α στην κυτταρική λειτουργία
Abstract
dc:descriptionHypoxia inducible factor HIF-2 is a transcriptional activator that mediates the cellular response to hypoxia. It is involved in physiological processes like development and differentiation, but also in pathological situations like cancer and inflammation. It acts as a heterodimer complex that consists of a hypoxia inducible subunit (HIF-2α) and a constitutively expressed subunit HIF-1β or ARNT. Regulation of HIF-2α involves oxygen-independent mechanisms, including post-translational modifications.In the first part of this thesis, we investigated the phosphorylation of HIF-2α by the casein kinase 1δ (CK1δ). We demonstrate that CK1δ phosphorylates HIF-2α at Ser383 and Thr528 in vitro. Disruption of these phosphorylation sites and silencing or chemical inhibition of CK1δ reduced the transcriptional activity of HIF-2 and the secretion of erythropoietin (EPO) in the two hepatic cancer cell lines tested, Huh7 and HepG2. Phosphorylation of Ser383 and Thr528 did not affect the protein stability of HIF-2α or its interaction with the specific co-activator USF2. However, immunofluorescence and subcellular localization assays showed that when CK1δ-dependent phosphorylation of HIF-2α was inhibited, we observed significant cytoplasmic mislocalization of HIF-2α. More strikingly, nuclear accumulation was re-established when nuclear protein export was inhibited upon addition of the CRM1 inhibitor Leptomycin B (LMB), suggesting that phosphorylation by CK1δ is required to maintain HIF-2α inside the nucleus where it gains access to its target genes, through inhibition of its CRM1 dependent nuclear export. Taken together these data suggest that CK1δ enhances EPO secretion from liver cancer cells under hypoxia by modifying HIF-2α and promoting its nuclear accumulation. The identification of this new oxygen-independent regulatory mechanism of HIF-2α could represent a potent therapeutic target in pathological situations that involve hypoxia and HIF-2. Considering the complicated relationship that exists between chronic inflammation and cancer in the development of hepatocellular carcinoma (HCC), in the second part of this thesis, we analyzed the effect of the pro-inflammatory cytokines TNF-α, IL-6 και IL-1β on HIF-2α, in comparison to the corresponding effect on HIF-1α in liver cancer cells. Our results showed that HIF-1α protein levels were increased in response to IL-1β and that its protein levels as well as its transcriptional activity were also augmented by IL-6 under hypoxia. However, HIF-2α was not influenced by the above cytokines at any level. TNF-α was found to act as a discriminating factor of the two HIF isoforms, since it activated the transcription of specific HIF-1 target genes like PGK, whereas it deactivated the transcription of specific HIF-w target genes like SOD2 and EPO. Immunofluorescence assays indicated that HIF-2α was significantly mislocalized to the cytoplasm in response to TNF-α and that this phenomenon was partially reversed upon Leptomycin B (LMB) treatment. Overall these data suggest that enhanced CRM1-mediated nuclear export is one of the reasons that could explain the observed HIF-2 partial inactivation under combined conditions of hypoxia and TNF-α in the Huh7 hepatocellular cancer cell line. However, we cannot exclude the possibility of other molecular mechanisms playing a role in this regulation, the clarification of which would contribute to better therapeutic strategies regarding the inflammation driven liver carcinogenesis.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Pangou, Evanthia
- Πάγγου, Ευανθία
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/39127